During the past decade, Dalin Tzu Chi Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 5 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dalin Tzu Chi Hospital" #1 sponsor was "Dalin Tzu Chi General Hospital" with 9 trials, followed by "Celgene" with 2 trials sponsored, "Chugai Pharma Taiwan" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dalin Tzu Chi Hospital" #1 collaborator was "Galapagos NV" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Buddhist Tzu Chi General Hospital" with 1 trials as a collaborator and "Chi Mei Medical Hospital" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Dalin Tzu Chi Hospital" are "Systemic Lupus Erythematosus" (3 trials), "Psoriatic Arthritis" (2 trials), "Tinnitus" (2 trials), "Acute Pain" (1 trials) and "Adherence, Treatment" (1 trials). Many other conditions were trialed in "Dalin Tzu Chi Hospital" in a lesser frequency.

Most popular intervention types in "Dalin Tzu Chi Hospital" are "Drug" (14 trials), "Other" (5 trials), "Dietary Supplement" (3 trials), "Procedure" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (2 trials), "Filgotinib" (2 trials), "Placebo to match filgotinib" (2 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dalin Tzu Chi Hospital" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Dalin Tzu Chi Hospital". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Dalin Tzu Chi Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Dalin Tzu Chi Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".